Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· LongevityLogicLabs

NMN vs. NR: The 2026 Verdict on the Best NAD+ Booster (Step 3)

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original language

*NMN vs. NR: The 2026 Verdict on the Best NAD+ Booster (Step 3)* A landmark January 2026 head-to-head human clinical trial has finally provided a definitive answer on the NMN vs. NR debate. If you are investing in your longevity, you need to understand how these precursors differ in blood-level elevation versus brain-tissue penetration. *MEDICAL DISCLAIMER:*This information is based on emerging clinical research and is intended for educational purposes only. It does not constitute medical advice, diagnosis, or treatment. NAD+ precursors are potent biological interventions. Always consult with a qualified healthcare professional before beginning any new supplementation or longevity regimen. *What you'll learn in this video:* 🔬 The biological difference between NMN and NR — and why it matters for YOUR cells. 📊 What the latest 2026 human trials reveal about NAD+ levels and tissue-specific bioavailability. 💊 A science-backed protocol for choosing the right precursor based on your age and biomarkers. 🧬 *OFFICIAL PROTOCOL DATABASE & VETTED SOURCES:* 👉 https://longevitylogiclabs.dub.link/Protocols (Access exact dosing, 2026 clinical data, and the lab-verified sources for this specific video.) 📄 The 2026 Head-to-Head Trial: Cuenoud B., et al. (2026). "Head-to-head comparison of NAD+ precursors NMN, NR, and nicotinamide in 65 healthy adults." Nature Metabolism. 🔗 https://bit.ly/Nature-NAD-Trial 🧠 The Norway Brain Study: "NR vs. NMN: Blood and Brain NAD+ Elevation in Parkinson’s Disease Research." (2026). Investigating blood-brain barrier penetration and cellular uptake. 🔗 https://bit.ly/Brain-NAD-Study 🧪 Bioavailability Analysis: Jinfiniti Clinical Review & MitoQ Science Journal. "NRK Pathway Analysis: Intracellular Bioavailability of NAD+ Precursors." 🔗 https://www.jinfiniti.com/nmn-and-nr/ ⏱ *TIMESTAMPS:* 0:00 Intro: The NAD+ Decline Problem 0:44 The Science: NMN vs. NR Pathways 2:22 The Protocol: Dosing & Stacking *SUPPORT THE CHANNEL:* If you found this research valuable, please Like and Subscribe to @LongevityLogicLabs. Our mission is to translate complex longevity science into actionable protocols. #NAD #NMN #NR #NicotinamideRiboside #Longevity #AntiAging #Biohacking #LongevityLogicsLabs

LongevityLogicLabs · 6 min · Source published: 2026-05-08

Added to Harbor: 10/22/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…